American Society of Hematology Annual Meeting & Exposition

newsroom

News
Research Summaries
Insights
Podcasts Q&As Video

Featured

Conference Coverage
red blood drop
Conference Coverage
Patients with Mantle Cell Lymphoma Treated With cBTKi With and Without Cytotoxic Chemotherapy
12/09/2024
Anthony Calabro, MA
Researchers analyzed data from a nationwide cohort to evaluate the effectiveness of covalent Bruton tyrosine kinase inhibitors, used either as monotherapy or in combination with anti-CD20 monoclonal...
12/09/2024
Conference Coverage
Conference Coverage
Conference Coverage
Is Outpatient Administration of Brexucabtagene Autoleucel Safe for Patients With Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma?
12/09/2024
Miranda Manier, BA
A retrospective study highlights the safety and feasibility of outpatient administration of brexucabtagene autoleucel for patients with acute lymphoblastic leukemia and mantle cell lymphoma, showing...
12/09/2024
Podcast
Nirmish R. Shah, MD
Podcast
The Use of Patient-Reported Outcomes to Assess Symptom Burden in Sickle Cell Disease
08/06/2024
Nirmish R. Shah, MD
In this podcast, Nirmish Shah, MD, discusses patient involvement and the use of patient-reported outcomes in the development of sickle cell disease interventions. Dr Shah’s team presented research on this...
08/06/2024

Conference Coverage

Conference Coverage
red blood drop
Conference Coverage
Patients with Mantle Cell Lymphoma Treated With cBTKi With and Without Cytotoxic Chemotherapy
12/09/2024
Anthony Calabro, MA
Researchers analyzed data from a nationwide cohort to evaluate the effectiveness of covalent Bruton tyrosine kinase inhibitors, used either as monotherapy or in combination with anti-CD20 monoclonal...
12/09/2024
Conference Coverage
Conference Coverage
Conference Coverage
Is Outpatient Administration of Brexucabtagene Autoleucel Safe for Patients With Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma?
12/09/2024
Miranda Manier, BA
A retrospective study highlights the safety and feasibility of outpatient administration of brexucabtagene autoleucel for patients with acute lymphoblastic leukemia and mantle cell lymphoma, showing...
12/09/2024
Conference Coverage
cc
Conference Coverage
Venetoclax-Based Treatments for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia Improves PFS Compared With Venetoclax Alone
02/23/2024
Anthony Calabro, MA
Researchers assessed the efficacy of venetoclax-based treatments for patients with relapsed/refractory chronic lymphocytic leukemia. This study was presented at the 65th ASH Annual Meeting & Exposition...
02/23/2024
Conference Coverage
cc
Conference Coverage
COVID-19 Pandemic Had Little Impact on Sickle Cell Disease Outcomes
12/18/2023
Anthony Calabro, MA
In effort to understand the effect of the COVID-19 pandemic among patients with sickle cell disease, researchers compared outcomes and characteristics of hospitalized patients both before and during the...
12/18/2023
Conference Coverage
doctor in white coat
Conference Coverage
Association Between Sickle Cell Trait and Patients With Leukemia Observed in National Inpatient Sample Study
12/12/2023
Anthony Calabro, MA
In their case-controlled study that utilized the National Inpatient Sample 2016-2019 database, researchers set out to examine the relationship between leukemia and sickle cell trait.
12/12/2023

Clinical Insights

Podcast
Nirmish R. Shah, MD
Podcast
The Use of Patient-Reported Outcomes to Assess Symptom Burden in Sickle Cell Disease
08/06/2024
Nirmish R. Shah, MD
In this podcast, Nirmish Shah, MD, discusses patient involvement and the use of patient-reported outcomes in the development of sickle cell disease interventions. Dr Shah’s team presented research on this...
08/06/2024
Video
Diana Abbott
Video
Treatment Outcomes in Elderly Patients Receiving First Line Therapy for Diffuse Large B-Cell Lymphoma
04/08/2024
Diana Abbott, PhD; Grace Bosma, MS
In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
04/08/2024
Conference Coverage
Nirmish R. Shah, MD
Conference Coverage
Use of Machine Learning to Predict Outcomes in Patients With Sickle Cell Disease Treated for Vaso-Occlusive Crisis
01/09/2024
Nirmish R. Shah, MD
In this podcast, Nirmish Shah, MD, discusses using machine learning and leveraging data analysis to make patient predictions about pain and readmission, to use interventions to minimize complications. Dr...
01/09/2024
Conference Coverage
Pinkal Desai, MD
Conference Coverage
Impact of Chemotherapy, Radiation in Patients Who Develop Acute Myeloid Leukemia, Myelodysplastic Syndrome
12/29/2023
Pinkal Desai, MD
In this podcast, Pinkal Desai, MD, discusses the impact of previous chemotherapy and/or radiation exposure in patients who go on to develop acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS),...
12/29/2023
Conference Coverage
Nirmish R. Shah, MD
Conference Coverage
Use of AB1 to Upregulate Fetal Hemoglobin in Patients With Sickle Cell Disease
12/22/2023
Nirmish R. Shah, MD
In this podcast, Nirmish Shah, MD, discusses an overview, the results, and the preclinical and clinical impact of the study titled Preclinical and Clinical Use of AB1, a DNMT1 Protein Depleter, to...
12/22/2023